JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhuang, H.
Right arrow Articles by Wojchowski, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhuang, H.
Right arrow Articles by Wojchowski, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 24, Issue of June 16, pp. 14500-14504, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Erythropoietin-dependent Inhibition of Apoptosis Is Supported by Carboxyl-truncated Receptor Forms and Blocked by Dominant-negative Forms of Jak2

Hongming Zhuang , Zhutian Niu , Tong-Chuan He , Sunil V. Patel , Don M. Wojchowski

Apoptosis, or programmed cell death (PCD), recently has emerged as an important homeostatic mechanism within several hematopoietic lineages. This process is subject to both positive and negative modulation by cytokines and within the erythroid lineage is inhibited by interleukin-3, stem cell factor, and erythropoietin (Epo). Through the expression of carboxyl-truncated Epo receptor mutants in FDC-P1 cells, a receptor form possessing 80 membrane-proximal cytoplasmic residues is shown to efficiently mediate Epo-dependent inhibition of PCD. This is in contrast to previous studies that attributed this activity to a distal carboxyl-terminal receptor subdomain (and/or heterodimerization of wild type Epo receptors with a truncated non-functional receptor form). Epo-dependent inhibition of PCD also is shown to be blocked by ectopic expression of kinase-deficient dominant-negative forms of Jak2 (Jak2VIII and Jak2-829), further underlining a role of this membrane-proximal subdomain of the Epo receptor in the inhibition of PCD. To our knowledge, this comprises the first direct evidence for an essential role for a Jak tyrosine kinase (Jak2) in this apoptotic response pathway.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. H. Gutzman, S. E. Nikolai, D. E. Rugowski, J. J. Watters, and L. A. Schuler
Prolactin and Estrogen Enhance the Activity of Activating Protein 1 in Breast Cancer Cells: Role of Extracellularly Regulated Kinase 1/2-Mediated Signals to c-fos
Mol. Endocrinol., July 1, 2005; 19(7): 1765 - 1778.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. H. Gutzman, D. E. Rugowski, M. D. Schroeder, J. J. Watters, and L. A. Schuler
Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
Mol. Endocrinol., December 1, 2004; 18(12): 3064 - 3075.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Li, M. P. Menon, V. G. Karur, S. Hegde, and D. M. Wojchowski
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells
Blood, November 1, 2003; 102(9): 3147 - 3153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Li, C. Miller, S. Hegde, and D. Wojchowski
Roles for an Epo Receptor Tyr-343 Stat5 Pathway in Proliferative Co-signaling with Kit
J. Biol. Chem., October 17, 2003; 278(42): 40702 - 40709.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Pelletier, F. Duhamel, P. Coulombe, M. R. Popoff, and S. Meloche
Rho Family GTPases Are Required for Activation of Jak/STAT Signaling by G Protein-Coupled Receptors
Mol. Cell. Biol., February 15, 2003; 23(4): 1316 - 1333.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Lin, L. Brown, D. W. Hedley, D. L. Barber, and S. Benchimol
The death-promoting activity of p53 can be inhibited by distinct signaling pathways
Blood, December 1, 2002; 100(12): 3990 - 4000.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. E. Lawson, H. Bao, A. Wickrema, S. M. Jacobs-Helber, and S. T. Sawyer
Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells
Blood, September 15, 2000; 96(6): 2084 - 2092.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Kashii, M. Uchida, K. Kirito, M. Tanaka, K. Nishijima, M. Toshima, T. Ando, K. Koizumi, T. Endoh, K.-i. Sawada, et al.
A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction
Blood, August 1, 2000; 96(3): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. C. Ward, I. Touw, and A. Yoshimura
The Jak-Stat pathway in normal and perturbed hematopoiesis
Blood, January 1, 2000; 95(1): 19 - 29.
[Full Text] [PDF]


Home page
BloodHome page
A. C. Oates, A. Brownlie, S. J. Pratt, D. V. Irvine, E. C. Liao, B. H. Paw, K. J. Dorian, S. L. Johnson, J. H. Postlethwait, L. I. Zon, et al.
Gene Duplication of Zebrafish JAK2 Homologs Is Accompanied by Divergent Embryonic Expression Patterns: Only jak2a Is Expressed During Erythropoiesis
Blood, October 15, 1999; 94(8): 2622 - 2636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Silva, A. Benito, C. Sanz, F. Prosper, D. Ekhterae, G. Nunez, and J. L. Fernandez-Luna
Erythropoietin Can Induce the Expression of Bcl-xL through Stat5 in Erythropoietin-dependent Progenitor Cell Lines
J. Biol. Chem., August 6, 1999; 274(32): 22165 - 22169.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Gregory, C. Yu, A. Ma, S. H. Orkin, G. A. Blobel, and M. J. Weiss
GATA-1 and Erythropoietin Cooperate to Promote Erythroid Cell Survival by Regulating bcl-xL Expression
Blood, July 1, 1999; 94(1): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. Jacobs-Helber, A. Wickrema, M. J. Birrer, and S. T. Sawyer
AP1 Regulation of Proliferation and Initiation of Apoptosis in Erythropoietin-Dependent Erythroid Cells
Mol. Cell. Biol., July 1, 1998; 18(7): 3699 - 3707.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
F. W. Quelle, J. Wang, J. Feng, D. Wang, J. L. Cleveland, J. N. Ihle, and G. P. Zambetti
Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
Genes & Dev., April 15, 1998; 12(8): 1099 - 1107.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. Guo, J. D. Dunbar, C. H. Yang, L. M. Pfeffer, and D. B. Donner
Induction of Jak/STAT Signaling by Activation of the Type 1 TNF Receptor
J. Immunol., March 15, 1998; 160(6): 2742 - 2750.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. J. Duhe, G. A. Evans, R. A. Erwin, R. A. Kirken, G. W. Cox, and W. L. Farrar
Nitric oxide and thiol redox regulation of Janus kinase activity
PNAS, January 6, 1998; 95(1): 126 - 131.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Joneja, H.-C. Chen, D. Seshasayee, A. L. Wrentmore, and D. M. Wojchowski
Mechanisms of Stem Cell Factor and Erythropoietin Proliferative Co-signaling in FDC2-ER Cells
Blood, November 1, 1997; 90(9): 3533 - 3545.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. O. Arcasoy, B. A. Degar, K. W. Harris, and B. G. Forget
Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene
Blood, June 15, 1997; 89(12): 4628 - 4635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Sakai and A. S. Kraft
The Kinase Domain of Jak2 Mediates Induction of Bcl-2 and Delays Cell Death in Hematopoietic Cells
J. Biol. Chem., May 9, 1997; 272(19): 12350 - 12358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Joneja and D. M. Wojchowski
Mitogenic Signaling and Inhibition of Apoptosis via the Erythropoietin Receptor Box-1 Domain
J. Biol. Chem., April 25, 1997; 272(17): 11176 - 11184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Jacobs-Helber, K. Penta, Z. Sun, A. Lawson, and S. T. Sawyer
Distinct Signaling from Stem Cell Factor and Erythropoietin in HCD57 Cells
J. Biol. Chem., March 14, 1997; 272(11): 6850 - 6853.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Schneider, W. Chaovapong, D. J. Matthews, C. Karkaria, R. T. Cass, H. Zhan, M. Boyle, T. Lorenzini, S. G. Elliott, and L. B. Giebel
Homodimerization of Erythropoietin Receptor by a Bivalent Monoclonal Antibody Triggers Cell Proliferation and Differentiation of Erythroid Precursors
Blood, January 15, 1997; 89(2): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. T. Sawyer and K. Penta
Association of JAK2 and STAT5 with Erythropoietin Receptors. ROLE OF RECEPTOR PHOSPHORYLATION IN ERYTHROPOIETIN SIGNAL TRANSDUCTION
J. Biol. Chem., December 13, 1996; 271(50): 32430 - 32437.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Nakamura, H. Chin, N. Miyasaka, and O. Miura
An Epidermal Growth Factor Receptor/Jak2 Tyrosine Kinase Domain Chimera Induces Tyrosine Phosphorylation of Stat5 and Transduces a Growth Signal in Hematopoietic Cells
J. Biol. Chem., August 9, 1996; 271(32): 19483 - 19488.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.